Provexis Plc PXS
Dividend Summary
There have not been any declared dividends recently.
Summary | Previous dividend | Next dividend |
---|---|---|
Status | – | – |
Type | – | – |
Per share | – | – |
Declaration date | – | – |
Ex-div date | – | – |
Pay date | – | – |
Enter the number of Provexis Plc shares you hold and we'll calculate your dividend payments:
Sign up for Provexis Plc and we'll email you the dividend information when they declare.
Add Provexis Plc to receive free notifications when they declare their dividends.
Your account is set up to receive Provexis Plc notifications.
Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
---|---|---|---|---|---|---|---|---|
There are no Provexis Plc dividends. |
Year | Amount | Change |
---|---|---|
2006 | 0.0p | — |
2007 | 0.0p | 0% |
2008 | 0.0p | 0% |
2009 | 0.0p | 0% |
2010 | 0.0p | 0% |
2011 | 0.0p | 0% |
2012 | 0.0p | 0% |
2013 | 0.0p | 0% |
2014 | 0.0p | 0% |
2015 | 0.0p | 0% |
2016 | 0.0p | 0% |
2017 | 0.0p | 0% |
2018 | 0.0p | 0% |
2019 | 0.0p | 0% |
2020 | 0.0p | 0% |
2021 | 0.0p | 0% |
2022 | 0.0p | 0% |
2023 | 0.0p | 0% |
2024 | Sign Up Required |
Provexis Plc Optimized Dividend Chart
- Dividend Yield Today
- 0.0%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 0.0% on 24 December 2023
- 52 Week Low
- 0.0% on 24 December 2023
- Next Ex-Div-Date Countdown
- Sign Up Required
About Provexis Plc
Provexis plc is a United Kingdom-based company, which is engaged in commercializing the Fruitflow anti-thrombotic technology. Fruitflow is a patented natural ingredient, which helps with platelet aggregation. Fruitflow has been shown in human trials to reduce the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can lead to heart attack and stroke. The extract is available in two formats, a syrup and a powder, and it can be included in a range of food, beverage and dietary supplement formats. Fruitflow is a concentrated form of bioactive, which is lycopene-free and contains approximately 30 anti-platelet compounds. The Company also offers Fruitflow+ Omega-3 dietary supplement products, which are available to purchase from the Company’s Website, e-commerce Website www.fruitflowplus.com. The Company’s subsidiaries include Provexis Nutrition Limited (PNL) and Provexis Natural Products Limited (PNP).
- Sector
- Pharmaceuticals & Biotechnology
- Country
- United Kingdom
- Share Price
- £0.01 (yesterday's closing price)
- Shares in Issue
- 2,263 million
- Market Cap
- £16mn
- 0
- Market Indices
- none